一个方法展示:利用最小的临床参数来评估COVID-19阳性患者早期死亡风险
1Sage Hill School, Newport Coast, CA, USA.
PeerJ. Computer science
|June 10, 2024
概括
预测COVID-19死亡率的机器学习模型只使用六个关键临床特征就能达到高准确度. 这种方法解决了获得广泛的健康数据的挑战,证明了与使用20多个参数的模型相似的性能.
科学领域:
- 医疗信息学 医疗信息学
- 机器学习在医学中的应用
- 临床数据分析 临床数据分析
背景情况:
- 数据稀缺会对机器学习 (ML) 模型的性能产生负面影响.
- 获取各种健康数据可能是昂贵和具有挑战性的.
- 对于 ML 方法有着至关重要的需求,这些方法可以在最小的临床特征下实现高精度.
研究的目的:
- 开发和评估一种方法,以使用最小的临床参数构建精确的ML模型.
- 确定预测COVID-19患者死亡率的最关键临床特征.
- 为了比较最小特征模型与综合特征模型的性能.
主要方法:
- 利用了1000多名COVID-19阳性患者的数据集.
- 开发了一个初始的机器学习模型,使用24个临床参数 (随机森林和后勤回归).
- 采用Shapley值和随机森林特征对于识别和选择六个最具预测力的临床特征至关重要.
主要成果:
- 最初的模型有24个特征,达到90%以上的准确性.
- 最终的模型仅使用了六个已识别的特征 (急性损伤,葡萄糖,年龄,热素,氧气水平,急性肝损伤),达到90% (随机森林) 和91% (后勤回归) 的准确性.
- 这一性能与利用所有24个特征的模型相美,证明了最小的,高度加权的参数的有效性.
结论:
- 一种新的方法允许开发高性能机器学习模型,但临床数据显著减少.
- 最小,高度加权的临床参数可以实现类似于在广泛数据集上训练的模型的性能指标.
- 鉴定的六个特征为预测COVID-19死亡率提供了一种实用方法,解决临床数据收集的挑战.
相关概念视频
01:20Actuarial Approach
74
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
74
01:24Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129
01:21Cancer Survival Analysis
343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
01:20Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177